Nephrology
CKD
1
Pipeline Programs↗
6
Active Trials↗
6
Companies Involved↗
CKD is an early-stage landscape with 1 program across 6 companies. The most active players are Renibus Therapeutics, Inc., Eli Lilly, Chong Kun Dang Pharmaceutical. 1 program is in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Approved
No programs
Analysis
Trial Status
54
clinical trials
Completed38 · 70%
Unknown status10 · 19%
Recruiting3 · 6%
Not yet recruiting2 · 4%
Active, not recruiting1 · 2%
Clinical Trials
Trial Activity
54 trials
Page 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)